Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company focused on translating the genetics of the adaptive immune system into clinical products for disease diagnosis and treatment [3] - The company aims to leverage the adaptive immune system's capabilities, which are considered nature's most finely tuned diagnostic and therapeutic tools for various diseases [3] Upcoming Event - The company will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, scheduled for January 14th at 5:15 p.m. Pacific Time / 8:15 p.m. Eastern Time [1][2] Business Focus - Adaptive Biotechnologies utilizes a proprietary immune medicine platform to decode the genetics of the adaptive immune system with scale, precision, and speed [3] - The company operates in two main business areas: Minimal Residual Disease (MRD) and Immune Medicine, focusing on the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases [3]